简体中文

Press releases

21 Jun 2025

Data from the Phase 2 Clinical Trial of CX11/VCT220 in China Presented at ADA 2025

Read article
17 Jun 2025

CORXEL Announces First Patient Enrolled in the U.S. Phase 2 Trial of CX11 in Obese and Overweight Patients

Read article
16 May 2025

CORXEL Announces First Patient Enrolled in ORION, the Registrational Clinical Trial of JX10 in Patients with Acute Ischemic Stroke

Read article
14 Apr 2025

CORXEL Receives Study May Proceed Letter from the U.S. FDA for the Phase 2 Trial of CX11 in Patients with Obesity and Overweight Conditions

Read article
26 Feb 2025

CORXEL Bolsters Leadership Team with Seasoned CFO Kevin Xie to Drive Next Phase of Company Growth

Read article
20 Feb 2025

CORXEL Announces China National Medical Products Administration Approval of the Clinical Trial Application for ORION, the Global Registrational Study of JX10 in Patients with Acute Ischemic Stroke

Read article
Load more

Developing innovative cardiometabolic therapies globally

Copyright © 2026 CORXEL. All Rights Reserved.
Designed & built by SampsonMay

沪ICP备20017872号-3

沪公网安备31010602008424号